Clinical Trials Gene Therapy Ophthalmology Regenerative Medicine Scientists use gene therapy and a novel light-sensing protein to restore vision in mice By Staff Reports 11 months ago A newly developed light-sensing protein called the MCO1 opsin restores vision in blind mice when
Biotechnology Gene Therapy Ophthalmology Regenerative Medicine UCI-led study reveals significant restoration of retinal and visual function following gene therapy By Staff Reports 11 months ago A breakthrough study, led by researchers from the University of California, Irvine, results in the
Biotechnology genes Ophthalmology Scientists Use Nanoparticle-Delivered Gene Therapy to Inhibit Blinding Eye Disease in Rodents By Staff Reports 1 year ago In experiments in rats and mice, two Johns Hopkins scientists — an engineer and an
Ophthalmology Autoimmune response drives vision loss in glaucoma By Staff Reports 3 years ago A research team from Massachusetts Eye and Ear and the Massachusetts Institute of Technology has
Ophthalmology Team from the University of Delaware has found the Protein that Triggers Degradation in the Eye By Staff Reports 3 years ago If you want to take clear photographs, you don’t use sandpaper to clear a smudge
Ophthalmology NIH Discovery Brings Stem Cell Therapy for Eye Disease Closer to the Clinic By Staff Reports 4 years ago Scientists at the National Eye Institute (NEI), part of the National Institutes of Health, report
Ophthalmology Biotech Agreement Advances Molecular Envelope Technology (MET) to develop a Cannabis-based Drops to Treat Glaucoma By Staff Reports 5 years ago NEMUS Bioscience, Inc. announced that the company has signed a development agreement with Nanomerics Ltd.
Biotechnology Ophthalmology FAU and Sancilio & Company, Inc. Collaborate to Further Develop Treatment for Retinitis Pigmentosa By Staff Reports 5 years ago Researchers from Florida Atlantic University are collaborating with scientists from Sancilio and Company, Inc., in
Biotechnology Clinical Trials Ophthalmology JCyte Completes Enrollment For Phase I/IIa Safety Trial By Staff Reports 5 years ago Company is poised to begin phase IIb efficacy trial in 2017 California-based regenerative medicine company
Cannabinoid Research Ophthalmology Cannabinoid-Based Therapeutics may present opportunity in Reducing Intraocular Pressure: Study By Staff Reports 5 years ago Data from a preclinical study presented last week at the 2016 AAPS National Meeting demonstrated
Clinical Trials Ophthalmology rare diseases Queen’s Researcher Explores Best Treatments for Glaucoma By Staff Reports 5 years ago Researchers at Queen’s University Belfast together with University of St Andrews and Aberdeen have found
Diabetes Ophthalmology Microbes In Your Gut Influence Major Eye Disease By Staff Reports 5 years ago Age-related Macular Degeneration (AMD) is the leading cause of irreversible blindness in the industrialized world,
Ophthalmology Saving Sight In Glaucoma: Why The Brain May Hold The Key By Staff Reports 5 years ago What causes vision loss in glaucoma? There are two common answers that at first may
Ophthalmology Promise Of Gene Therapy For Glaucoma Shines Bright In Award-Winning Image By Staff Reports 5 years ago Whether you see the gossamer wings of a butterfly or the delicate opened petals of
Neurology Ophthalmology Visual Cortex Plays Role In Plasticity Of Eye Movement Reflex By Staff Reports 5 years ago By peering into the eyes of mice and tracking their ocular movements, researchers made an
Cannabinoid Research Ophthalmology Pharmaceuticals New Class of Medicinals based on Cannabinoid Molecules, Spurs NEMUS Bioscience Inc. into Action By Staff Reports 5 years ago Q&A with Brian Murphy MD, CEO/CMO, NEMUS Bioscience Humans produce a range of chemical compounds